×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
FENC – fennec pharmaceuticals inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
FENC
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/20
06:06 am
fenc
Fennec Pharmaceuticals Inc (NASDAQ: FENC) was upgraded by analysts at Stephens to a "strong-buy" rating.
Medium
Report
Fennec Pharmaceuticals Inc (NASDAQ: FENC) was upgraded by analysts at Stephens to a "strong-buy" rating.
11/13
06:27 am
fenc
Fennec Pharmaceuticals to Participate in Upcoming Investor Conference
Medium
Report
Fennec Pharmaceuticals to Participate in Upcoming Investor Conference
11/12
05:39 am
fenc
Fennec Pharmaceuticals Third Quarter 2024 Earnings: Misses Expectations [Yahoo! Finance]
Low
Report
Fennec Pharmaceuticals Third Quarter 2024 Earnings: Misses Expectations [Yahoo! Finance]
11/9
02:14 am
fenc
Fennec Pharmaceuticals Inc (FENC) Q3 2024 Earnings Call Highlights: Strong Sales Growth and ... [Yahoo! Finance]
Medium
Report
Fennec Pharmaceuticals Inc (FENC) Q3 2024 Earnings Call Highlights: Strong Sales Growth and ... [Yahoo! Finance]
11/7
06:16 am
fenc
Fennec Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]
High
Report
Fennec Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]
11/7
06:13 am
fenc
Fennec Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update
High
Report
Fennec Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update
10/31
06:26 am
fenc
Fennec Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 7, 2024 [Financial Post (Toronto, Ontario, Canada)]
Medium
Report
Fennec Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 7, 2024 [Financial Post (Toronto, Ontario, Canada)]
10/31
06:25 am
fenc
Fennec Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 7, 2024 [Yahoo! Finance]
Medium
Report
Fennec Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 7, 2024 [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
11/7/2024
06:13 am
fenc
fennec pharmaceuticals inc.
MISS
Report
-11.9%
fennec pharmaceuticals inc.
8/13/2024
06:05 am
fenc
fennec pharmaceuticals inc.
MISS
Report
-5.3%
fennec pharmaceuticals inc.
5/14/2024
06:03 am
fenc
fennec pharmaceuticals inc.
MISS
Report
-28.0%
fennec pharmaceuticals inc.
3/21/2024
06:00 am
fenc
fennec pharmaceuticals inc.
MISS
Report
-11.4%
fennec pharmaceuticals inc.
Date
Time
Symbol
Headline
Impact
11/18
05:03 pm
fenc
Form 4 FENNEC PHARMACEUTICALS For: Nov 18 Filed by: Andrade Robert
Medium
Report
Form 4 FENNEC PHARMACEUTICALS For: Nov 18 Filed by: Andrade Robert
11/14
01:59 pm
fenc
Form SCHEDULE 13G/A FENNEC PHARMACEUTICALS Filed by: Solas Capital Management, LLC
Low
Report
Form SCHEDULE 13G/A FENNEC PHARMACEUTICALS Filed by: Solas Capital Management, LLC
11/13
05:15 pm
fenc
Form 4 FENNEC PHARMACEUTICALS For: Nov 13 Filed by: Cioffi Christiana Marie
Low
Report
Form 4 FENNEC PHARMACEUTICALS For: Nov 13 Filed by: Cioffi Christiana Marie
11/13
05:14 pm
fenc
Form 4 FENNEC PHARMACEUTICALS For: Nov 13 Filed by: Evans Terry L
Low
Report
Form 4 FENNEC PHARMACEUTICALS For: Nov 13 Filed by: Evans Terry L
11/13
05:13 pm
fenc
Form 4 FENNEC PHARMACEUTICALS For: Nov 13 Filed by: Sayad Pierre Sargis
Low
Report
Form 4 FENNEC PHARMACEUTICALS For: Nov 13 Filed by: Sayad Pierre Sargis
11/12
07:38 pm
fenc
Form SC 13G/A FENNEC PHARMACEUTICALS Filed by: DG Capital Management, LLC
Medium
Report
Form SC 13G/A FENNEC PHARMACEUTICALS Filed by: DG Capital Management, LLC
11/8
04:49 pm
fenc
Form 10-Q FENNEC PHARMACEUTICALS For: Sep 30
Low
Report
Form 10-Q FENNEC PHARMACEUTICALS For: Sep 30
11/4
05:30 pm
fenc
Form 4 FENNEC PHARMACEUTICALS For: Oct 31 Filed by: Andrade Robert
Low
Report
Form 4 FENNEC PHARMACEUTICALS For: Oct 31 Filed by: Andrade Robert
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
4/13
Fennec Pharmaceuticals Announces FDA Filing Acceptance and Priority Review of New Drug Application for PEDMARK™
11.9%
3/5 Form 8-K FENNEC PHARMACEUTICALS For: Mar 05 8.0%
2/11 Fennec Pharmaceuticals Completes Rolling Submission of New Drug Application (NDA) to U.S. Food and Drug Administration for PEDMARK™ and Also Submits Marketing Authorization Application (MAA) to European Medicines Agency 7.8%
7/30 Fennec Pharmaceuticals Inc (NASDAQ: FENC) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. 5.6%
12/23 Hedge Funds Aren’t Crazy About Contango Oil & Gas Company (MCF) Anymore [Yahoo! Finance News] 3.7%
2/14 Q4/2019 12/31/2019 EPS -0.180 ZacksConsensus N/A ActVsEst N/A - N/A 3.6%
5/16 Form DEF 14A FENNEC PHARMACEUTICALS For: Jun 18 1.9%
2/18 Fennec Pharmaceuticals Inc (NASDAQ: FENC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $17.00 price target on the stock. 1.7%
5/14 Fennec Pharmaceuticals Inc (NASDAQ: FENC) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $4.50 price target on the stock. 1.7%
4/30 Fennec Announces Pricing of Public Offering 1.6%
3/5 Form 8-K FENNEC PHARMACEUTICALS For: Mar 05 8.0%
2/11 Fennec Pharmaceuticals Completes Rolling Submission of New Drug Application (NDA) to U.S. Food and Drug Administration for PEDMARK™ and Also Submits Marketing Authorization Application (MAA) to European Medicines Agency 7.8%
7/30 Fennec Pharmaceuticals Inc (NASDAQ: FENC) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. 5.6%
12/23 Hedge Funds Aren’t Crazy About Contango Oil & Gas Company (MCF) Anymore [Yahoo! Finance News] 3.7%
2/14 Q4/2019 12/31/2019 EPS -0.180 ZacksConsensus N/A ActVsEst N/A - N/A 3.6%
5/16 Form DEF 14A FENNEC PHARMACEUTICALS For: Jun 18 1.9%
2/18 Fennec Pharmaceuticals Inc (NASDAQ: FENC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $17.00 price target on the stock. 1.7%
5/14 Fennec Pharmaceuticals Inc (NASDAQ: FENC) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $4.50 price target on the stock. 1.7%
4/30 Fennec Announces Pricing of Public Offering 1.6%
TOP News Decliners
4/29
Fennec Announces Proposed Public Offering of Common Shares
-13.6%
4/15 Fennec Pharmaceuticals Inc (NASDAQ: FENC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $17.00 price target on the stock. -11.9%
6/19 Fennec Announces Results of Annual Meeting -8.0%
4/7 Fennec Pharmaceuticals Inc (NASDAQ: FENC) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -6.7%
1/14 Fennec Pharmaceuticals Inc (NASDAQ: FENC) was downgraded by analysts at Zacks Investment Research from a "strong-buy" rating to a "hold" rating. -3.9%
4/13 Form 8-K FENNEC PHARMACEUTICALS For: Apr 13 -3.9%
12/2 Fennec Pharmaceuticals Inc (NASDAQ: FENC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $17.00 price target on the stock. -3.7%
5/9 Form 8-K FENNEC PHARMACEUTICALS For: May 09 -2.6%
6/26 Form S-8 FENNEC PHARMACEUTICALS -2.4%
11/12 Q3/2019 9/30/2019 EPS -0.090 ZacksConsensus -0.230 ActVsEst 0.140 - Beat -2.0%
4/15 Fennec Pharmaceuticals Inc (NASDAQ: FENC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $17.00 price target on the stock. -11.9%
6/19 Fennec Announces Results of Annual Meeting -8.0%
4/7 Fennec Pharmaceuticals Inc (NASDAQ: FENC) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -6.7%
1/14 Fennec Pharmaceuticals Inc (NASDAQ: FENC) was downgraded by analysts at Zacks Investment Research from a "strong-buy" rating to a "hold" rating. -3.9%
4/13 Form 8-K FENNEC PHARMACEUTICALS For: Apr 13 -3.9%
12/2 Fennec Pharmaceuticals Inc (NASDAQ: FENC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $17.00 price target on the stock. -3.7%
5/9 Form 8-K FENNEC PHARMACEUTICALS For: May 09 -2.6%
6/26 Form S-8 FENNEC PHARMACEUTICALS -2.4%
11/12 Q3/2019 9/30/2019 EPS -0.090 ZacksConsensus -0.230 ActVsEst 0.140 - Beat -2.0%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: